Macrovascular disease and risk factors in youth with type 1 diabetes: time to be more attentive to treatment?

Publication date: Available online 20 February 2018Source: The Lancet Diabetes & EndocrinologyAuthor(s): Petter Bjornstad, Kim C Donaghue, David M MaahsSummaryCardiovascular disease remains the leading cause of mortality in patients with type 1 diabetes. Although cardiovascular disease complications are rare until adulthood, pathology and early markers can manifest in adolescence. Whereas advances have been made in the management of microvascular complications of type 1 diabetes, similar progress in reducing macrovascular complications has not been made. The reasons for the absence of progress remain incompletely understood, but most likely relate to the long time needed for cardiovascular disease to manifest clinically and hence for risk factor management to show a clinical benefit, thus allowing inertia to prevail for diagnosis and particularly for targeting risk factors. In this Review, we summarise paediatric data on traditional and novel risk factors of cardiovascular disease, provide an overview of data from previous and current clinical trials, discuss future directions in cardiovascular disease research for paediatric patients with type 1 diabetes, and advocate for the early identification and treatment of cardiovascular disease risk factors as recommended in multiple guidelines.
Source: The Lancet Diabetes and Endocrinology - Category: Endocrinology Source Type: research